Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10292 |
| Vaccine Name | BVRS-GamVac |
| Disease Name | MERS |
| Disease Classification | Respiratory |
| Virus Name | MERS-CoV |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Non-replicating viral vector |
| Vaccine Status | Phase 2 |
| Manufacturer | Gamaleya Research Institute of Epidemiology and Microbiology |
| Year of Manufacturing | 2021 |
| Manufacturing Country | Russia |
| Age | 18 - 55 years |
| Dosage | NA |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | MERS CoV spike glycoprotein |
| Description | NA |
| Approving Organisation | NA |
| Collaborating Organisation | Health Ministry of the Russian Federation |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NCT04130594 |
| Reference Link | https://clinicaltrials.gov/ct2/show/NCT04130594?cond=MERS-CoV&phase=0123&draw=2&rank=14 |
| Additional Links | NA |